JOB OPPORTUNITIES!

  • Please come back regularly.

 

Applications closed:

  • PSI

PSI-FELLOW-III-3i / Postdoctoral Fellows (f/m/d)

The Paul Scherrer Institute PSI is the largest research institute for natural and engineering sciences within Switzerland. We perform cutting-edge research in the fields of matter and materials, energy and environment and human health. By performing fundamental and applied research, we work on sustainable solutions for major challenges facing society, science and economy. PSI is committed to the training of future generations. Therefore, about one quarter of our staff are post-docs, post-graduates or apprentices. Altogether, PSI employs 2100 people.

In the framework of the international fellowship program with the acronym: "PSI-FELLOW-III-3i", the PSI is inviting experienced researchers (Postdocs) from all over the world to submit their applications for research positions that are part of our new postdoctoral program. Our "3i or triple i" postdoctoral program offers unique opportunities for scientific and career development with international, interdisciplinary and inter-sectoral prospects. Our postdoctoral program is a Horizon2020 Marie Sklodowska-Curie COFUND Action (grant agreement 884104).

We have put forward a theme titled "Mass separation and laser ionization towards Isotope Separation OnLine (ISOL) techniques" (listing at https://www.psi.ch/en/psi-fellow/list-of-principle-investigators-and-themes) . This position deals with the R&D of the on-line laser resonance ionization and mass separation for the ISOL-based radionuclide production as part of the IMPACT large facility initiative (https://www.psi.ch/en/impact) and is expected to be extended during the construction phase of IMPACT into a tenure-track permanent scientist position for TATTOOS in 2025.

The deadline for applications will be 30 November 2022, 24:00 CET.

Please connect to the job-offer website and the PSI-FELLOW-III-3i website (links below) and obtain important information about the eligibility criteria and the application process.

Link to full posting:

https://www.psi.ch/en/pa/job-opportunities/53237-psi-fellow-iii-3i-postdoctoral-fellows-fmd

https://www.psi.ch/psi-fellow/psi-fellow

Please contact Nick van der Meulen, if you are interested.

 

  • TRIUMF

Opening for  a postdoc position at TRIUMF with a focus on mercury-197 radiochemistry and chelation. More details on https://triumf.wd10.myworkdayjobs.com/en-US/careers-at-triumf-job-posti…, post JR100262

  • Open job opportunities within the DOE Isotope Program Community. More info here.
  1. Postdoctoral Scholar - Radiation Oncology, University of Michigan
  2. Linac Facility Engineer/Accelerator Operator, Argonne National Laboratory
  3. Accelerator Operator, Argonne National Laboratory
  • AAA/Novartis - Italy

The Advanced Accelerator Applications, a Novartis company, is searching for a Research Senior Scientist for the New Isotopes Research group, who will be based in Italy. More information here.

  • CERN - ISOLDE

PhD thesis on production and purification of metastable Xenon for the gamma-MRI project at CERN. Deadline for application 24th of March 2021. More information here.

  • GSI - Facility for Antiproton and Ion Research

GSI - FAIR in Darmstadt (Germany) is looking for a Postdoctoral Researcher with a PhD in Nuclear Physics (posting ID: 1230-20.52) to join a multidisciplinary team of experts in nuclear and atomic physics, ion optics, PET imaging and biophysics. The term of appointment is for 3 years. Applicants are invited to submit a cover letter, a CV that includes contact information for three references and a publication list by September 6th 2020 via e-mail to bewerbung@gsi.de

  • Hevesy Lab

Hevesy Lab at DTU Riso, Denmark, has an open permanent position for a "Cyclotron & Radionuclide Specialist for Medical Isotopes". Deadline for application 21st of May 2020. More information on the vacancy note can be found here.

  • SCK CEN

SCK CEN, Mol, Belgium, has an open position for a "Researcher for preclinical studies of radiopharmaceuticals". Deadline for application 3rd of June 2020. More information on the vacancy note can be found here.

  • GANIL

Target and ion source développement permanent position open at GANIL. Deadline for application 2nd July. More information can be found on French CNRS website (select consultez les offres/Normandie).

  • Fermilab

FNL is looking for a senior target scientist to develop its Mu2e target station. More info here.

  • KULeuven/JRC Karlsruhe

Joint PhD position at KULeuven - JRC_Karlsruhe. More info here

NEWS!

  • 06/2023

MEDICIS recent achievements have been presented during invited presentations at the ARIS2023 conference (Avignon, France) and the 16th conference on nuclear reaction mechanisms (Varenna, Italy)

  • 16/05/2023

Recent technical developments such as the online activity monitoring during implantation and the definition of Key Performance Indicators for MEDICIS were reported at EMIS2022 and IPAC2023 conferences. Related EMIS and IPAC publications.

  • 10/03/2023

Three new project proposals were submitted at the 10th MEDICIS Collaboration board, with a notable request to translate one of the MEDICIS High Molar Activity radionuclides in a clinical settings.

  • 15/11/2022

The Frontiers Research Topics : MEDICIS-Promed, Advances in Radioactive Ion Beams for Nuclear Medicine is now published. It can be downloaded from there.

  • 26/09/2022

The half-life of Tb-155 produced at MEDICIS has been revised and is now published by S. Collins et al. in Applied Radiation and Isotope. High molar activity Sm-153 was 1st used in Targeted Radionuclide Therapy and theranostics (MED-025) by M. Ooms et al, as presented at TERACHEM.

 

JOB OPPORTUNITIES

  • The Belgian Nuclear Research Centre SCK CEN seeks to fill a permanent researcher position within the MYRRHA project, as ISOL physicist. Application deadline 10 Sept 23 . Informal contact can be made to Lucia Popescu.

A KNOWLEDGE TRANSFER SUCCESS STORY

Read more ...

GRANTS & DONATIONS - CERN & Society Foundation

The CERN KT-Fund

La Fondation pour l'innovation sur le cancer et la biologie

The ADAM company

The FWO

  PRISMAP and EURAMED in H2020 European commission